rs17290301
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005228.5(EGFR):c.2061+65G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0236 in 1,592,892 control chromosomes in the GnomAD database, including 503 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 34 hom., cov: 33)
Exomes 𝑓: 0.024 ( 469 hom. )
Consequence
EGFR
NM_005228.5 intron
NM_005228.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.42
Publications
8 publications found
Genes affected
EGFR (HGNC:3236): (epidermal growth factor receptor) The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). [provided by RefSeq, Jul 2020]
EGFR Gene-Disease associations (from GenCC):
- lung cancerInheritance: AD Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
- non-small cell lung carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- inflammatory skin and bowel disease, neonatal, 2Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- neonatal inflammatory skin and bowel diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 7-55173189-G-A is Benign according to our data. Variant chr7-55173189-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1174198.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0199 (3034/152360) while in subpopulation NFE AF = 0.0281 (1915/68032). AF 95% confidence interval is 0.0271. There are 34 homozygotes in GnomAd4. There are 1368 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 34 AD,AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EGFR | ENST00000275493.7 | c.2061+65G>A | intron_variant | Intron 17 of 27 | 1 | NM_005228.5 | ENSP00000275493.2 | |||
EGFR | ENST00000455089.5 | c.1926+65G>A | intron_variant | Intron 16 of 25 | 1 | ENSP00000415559.1 | ||||
EGFR | ENST00000450046.2 | c.1902+65G>A | intron_variant | Intron 17 of 27 | 4 | ENSP00000413354.2 | ||||
EGFR | ENST00000700145.1 | c.408+65G>A | intron_variant | Intron 4 of 8 | ENSP00000514824.1 |
Frequencies
GnomAD3 genomes AF: 0.0200 AC: 3039AN: 152242Hom.: 34 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
3039
AN:
152242
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0240 AC: 34603AN: 1440532Hom.: 469 AF XY: 0.0240 AC XY: 17167AN XY: 715922 show subpopulations
GnomAD4 exome
AF:
AC:
34603
AN:
1440532
Hom.:
AF XY:
AC XY:
17167
AN XY:
715922
show subpopulations
African (AFR)
AF:
AC:
338
AN:
33230
American (AMR)
AF:
AC:
772
AN:
44394
Ashkenazi Jewish (ASJ)
AF:
AC:
933
AN:
25950
East Asian (EAS)
AF:
AC:
5
AN:
39556
South Asian (SAS)
AF:
AC:
1365
AN:
85938
European-Finnish (FIN)
AF:
AC:
382
AN:
41520
Middle Eastern (MID)
AF:
AC:
204
AN:
4544
European-Non Finnish (NFE)
AF:
AC:
29052
AN:
1105598
Other (OTH)
AF:
AC:
1552
AN:
59802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1851
3702
5554
7405
9256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1044
2088
3132
4176
5220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0199 AC: 3034AN: 152360Hom.: 34 Cov.: 33 AF XY: 0.0184 AC XY: 1368AN XY: 74504 show subpopulations
GnomAD4 genome
AF:
AC:
3034
AN:
152360
Hom.:
Cov.:
33
AF XY:
AC XY:
1368
AN XY:
74504
show subpopulations
African (AFR)
AF:
AC:
431
AN:
41594
American (AMR)
AF:
AC:
310
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
142
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5186
South Asian (SAS)
AF:
AC:
74
AN:
4826
European-Finnish (FIN)
AF:
AC:
74
AN:
10620
Middle Eastern (MID)
AF:
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1915
AN:
68032
Other (OTH)
AF:
AC:
55
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
159
318
478
637
796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
33
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 16, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.